US3814668A - Method and device for the semi-quantitative determination of glucose in aqueous fluids - Google Patents
Method and device for the semi-quantitative determination of glucose in aqueous fluids Download PDFInfo
- Publication number
- US3814668A US3814668A US00866730A US86673069A US3814668A US 3814668 A US3814668 A US 3814668A US 00866730 A US00866730 A US 00866730A US 86673069 A US86673069 A US 86673069A US 3814668 A US3814668 A US 3814668A
- Authority
- US
- United States
- Prior art keywords
- glucose
- test
- semi
- test device
- iodide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000008103 glucose Substances 0.000 title abstract description 42
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title abstract description 40
- 238000000034 method Methods 0.000 title abstract description 11
- 239000012530 fluid Substances 0.000 title abstract description 9
- 238000012360 testing method Methods 0.000 abstract description 77
- 239000000463 material Substances 0.000 abstract description 27
- 239000000203 mixture Substances 0.000 abstract description 27
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 abstract description 17
- 210000002700 urine Anatomy 0.000 abstract description 17
- 108010015776 Glucose oxidase Proteins 0.000 abstract description 12
- 239000004366 Glucose oxidase Substances 0.000 abstract description 11
- 229940116332 glucose oxidase Drugs 0.000 abstract description 11
- 235000019420 glucose oxidase Nutrition 0.000 abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 11
- 230000003617 peroxidasic effect Effects 0.000 abstract description 10
- 239000000126 substance Substances 0.000 abstract description 10
- 239000012528 membrane Substances 0.000 abstract description 9
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 abstract description 7
- 239000001856 Ethyl cellulose Substances 0.000 abstract description 7
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 abstract description 7
- 229920001249 ethyl cellulose Polymers 0.000 abstract description 7
- 235000019325 ethyl cellulose Nutrition 0.000 abstract description 7
- 235000012745 brilliant blue FCF Nutrition 0.000 abstract description 6
- 239000004161 brilliant blue FCF Substances 0.000 abstract description 6
- 229940055580 brilliant blue fcf Drugs 0.000 abstract description 6
- 238000004040 coloring Methods 0.000 abstract description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 18
- 239000000243 solution Substances 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 12
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 9
- 230000002209 hydrophobic effect Effects 0.000 description 8
- 230000002255 enzymatic effect Effects 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 102000003992 Peroxidases Human genes 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 229920003086 cellulose ether Polymers 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 108040007629 peroxidase activity proteins Proteins 0.000 description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- XZXYQEHISUMZAT-UHFFFAOYSA-N 2-[(2-hydroxy-5-methylphenyl)methyl]-4-methylphenol Chemical compound CC1=CC=C(O)C(CC=2C(=CC=C(C)C=2)O)=C1 XZXYQEHISUMZAT-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 229940107816 ammonium iodide Drugs 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 235000009518 sodium iodide Nutrition 0.000 description 3
- IKHKJYWPWWBSFZ-UHFFFAOYSA-N 4-[[4-(diethylamino)phenyl]-(4-diethylazaniumylidenecyclohexa-2,5-dien-1-ylidene)methyl]benzene-1,3-disulfonate;hydron Chemical compound C1=CC(N(CC)CC)=CC=C1C(C=1C(=CC(=CC=1)S([O-])(=O)=O)S(O)(=O)=O)=C1C=CC(=[N+](CC)CC)C=C1 IKHKJYWPWWBSFZ-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- SJEYSFABYSGQBG-UHFFFAOYSA-M Patent blue Chemical compound [Na+].C1=CC(N(CC)CC)=CC=C1C(C=1C(=CC(=CC=1)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=CC(=[N+](CC)CC)C=C1 SJEYSFABYSGQBG-UHFFFAOYSA-M 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 150000004694 iodide salts Chemical class 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000009738 saturating Methods 0.000 description 2
- XOSXWYQMOYSSKB-LDKJGXKFSA-L water blue Chemical compound CC1=CC(/C(\C(C=C2)=CC=C2NC(C=C2)=CC=C2S([O-])(=O)=O)=C(\C=C2)/C=C/C\2=N\C(C=C2)=CC=C2S([O-])(=O)=O)=CC(S(O)(=O)=O)=C1N.[Na+].[Na+] XOSXWYQMOYSSKB-LDKJGXKFSA-L 0.000 description 2
- SPFMQWBKVUQXJV-BTVCFUMJSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;hydrate Chemical compound O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O SPFMQWBKVUQXJV-BTVCFUMJSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- NUIURNJTPRWVAP-UHFFFAOYSA-N 3,3'-Dimethylbenzidine Chemical compound C1=C(N)C(C)=CC(C=2C=C(C)C(N)=CC=2)=C1 NUIURNJTPRWVAP-UHFFFAOYSA-N 0.000 description 1
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 101100168115 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) con-6 gene Proteins 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229960004543 anhydrous citric acid Drugs 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000013142 basic testing Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 108010046301 glucose peroxidase Proteins 0.000 description 1
- 230000035780 glucosuria Effects 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- KHLVKKOJDHCJMG-QDBORUFSSA-L indigo carmine Chemical compound [Na+].[Na+].N/1C2=CC=C(S([O-])(=O)=O)C=C2C(=O)C\1=C1/NC2=CC=C(S(=O)(=O)[O-])C=C2C1=O KHLVKKOJDHCJMG-QDBORUFSSA-L 0.000 description 1
- 229960003988 indigo carmine Drugs 0.000 description 1
- 235000012738 indigotine Nutrition 0.000 description 1
- 239000004179 indigotine Substances 0.000 description 1
- 239000011872 intimate mixture Substances 0.000 description 1
- 229940006461 iodide ion Drugs 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- XPFJYKARVSSRHE-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].[Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O XPFJYKARVSSRHE-UHFFFAOYSA-K 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/805—Test papers
Definitions
- test device as in claim 1 wherein the test device further includes a buffer for maintaining the system in a pH range of from about pH 3.4 to pH 7.2.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Improved method and device for the semi-quantitative determination of glucose in aqueous fluids such as urine comprising glucose oxidase, a water soluble iodide salt, and a substance having peroxidative activity. The composition is incorporated with a carrier member therefor and/or a semi-permeable membrane such as ethylcellulose. A preferable embodiment of the present invention comprises the inclusion of a background coloring material such as brilliant blue FCF in the test composition.
Description
United States Patent METHOD AND DEVICE FOR THE SEMI-QUANTI- TATIVE DETERMINA'IION 0F GLUCOSE IN AQUEOUS FLUIDS Kenneth Allen Blake Billy Ihrperflhden, and William Fred Hendershot, Ellrhart, Ind., and Laveli Rolfson Johnson, Salt Lake City, Utah, sssignors to Miles Laboratories, Inc, Elirhart, Ind.
No Drawing. Filed Oct. 15, 1969, Ser. No. 866,730 Int. Cl. G01n 31/14 US. Cl. 195-103.5 C 16 Claims ABSTRACT OF THE DISCLOSURE Improved method and device for the semi-quantitative determination of glucose in aqueous-fluids such as urine comprisingglucose oxidase, a water soluble iodide salt, and a substance having peroxidative activity. The composition is incorporated with a carrier member therefor and/or a semi-permeable membrane such as ethylcellulose. A preferable embodiment of the present invention comprises the inclusion-of a background coloring material such as brilliant blue FCF in the test composition.
BACKGROUND OF THE PRESENT INVENTION The detection of gucose in urine as well as the determination of its concentration therein is of great importance for diabetic patients who must control theirdiets so as to regulate their sugar intake and who must frequently be guided in this regard bye-regular check on urine glucose. But beyond its usefulness in regular urine testing on known diabetics by both patients and physicians, this glucose indicator may aisobe used eificiently in routine urinalysis in hospitals and physicians" offices, in diabetes detection and screening programs, in the diflerentiation of glucosuria from other meliturias, and the like.
Because early diagnosis and continued controlarevso important in diabetes, a urine-sugar test, to.be of.- the greatest value, must be conveniently rapid, simpleenough for any patient to use with ease, accurate enough to serve the clinician, and sensitive enough to reflect variations in the patients condition. Morever, the test device must be sufliciently quantitative to accurately measure increments of glucose concentration'and th'us diflerentiate various medical conditions.
Procedures forthe detection andestim'ation-of'sugss' in urine are well known in clinical chemistry. One such procedure utilizes Benedict's copper reduction test, an-
other employs a self heating alkaline copper reduction test in table form, still another involvesstestwhichrdepends solely on the actionof enzymes. This latterenzymatie glucose test, comprises the presence of glucose oxidase, s peroxidative material, and achromogen which responds when the test composition is contacted witha body fluid containing glucose. Such indicator materials are generally oxidation-reduction indicators.
The enzymatic glucose test systems described hereinabove, have usually been incorporated with a carrier means therefor. Such carrier means usually comprise bibulous celluolse strips into or unto which the test composition is incorporated. It has been found, however, that such enzymatic glucose test devices are notsutiiciently quantitative, that is, they are not -capable of differentiating 3,814,668 Patented June 4. 1974 p CC small increments of glucose in body fluids such as urine.
Therefore, a primary obiectof the present invention is to provide an improvedsemi-quantitative glucose test capable of differentiating small increments of glucose in body fluids such as urine. It is another object to provide an improved glucose test device having excellent stability characteristics. it is yet another object of the present invention to provide a dip and read glucose test device having controlled sample retention properties.
SUMMARY .OF THE INVENTION It has now been found that the above and other objects may be achieved by employing a glucose test formulation comprising glucose oxidase, a peroxidative active substance, and a water soluble iodide salt incorporated with a carrier member and/or coated with a semi-permeable membrane such as with ethyl cellulose, thus achieving a controlled pick up and retention of sample liquid when immersed therein. A preferable embodiment of the present invention comprises incorporating a background coloring material such as a blue dye in the test composition so as to achieve an unusually broad color gradient response.
DESCRIPTION OF THE PREFERRED EMBOD] MENTS As noted hereinabove, it has now been found that the superior semi-quantitative glucose test can be achieved by the utilization of a water soluble iodide as a chromogcn in an enzymatic glucose test system. However, the mere utilization of such an iodide is not sufficient to achieve the desired results. it has been foundvthat if a test device comprising simply glucose oxidase, peroxidase, and an iodide salt is immersed into a urine sample containing glucose and immediately withdrawn therefrom, the relention of excess sample liquid onvthe test device prevents the atmospheric oxygen from reaching the test reaction with the result that the reaction is said to cycle. That is, it is believed that when oxygen is excluded from reaching the, test reaction by. a layer of liquid over the device, a portion of the free iodine acts as an oxidizing agent for the reduced glucose oxidase formed in the reaction. Thus, the iodide does not function as efficiently as an indicator material but participates in the glucose oxidase-glucose reaction.
It has now been found that if a means is provided to prevent the retention of excess liquid sample on the test device, the iodide rather than participating in the glucose oxidase-glucose reaction, functions as an indicator material, thus giving excellent semi-quantitative results.
Thus, it has been found that it's semi-permeable membrane is applied to the surface of an enzymatic glucose test device, or an enzymatic test composition incorporated with a semi-permeable membrane or film forming polymericsubstance, the membrane acts as a means for preventing excess liquid from adhering to the test device allowing atmospheric oxygen to reach the test reaction and consequently permitting the iodide to go to free iodine and functioning eflectively as an indicator material.
The iodide salts contemplated for use in the system of the present invention are those which readily ionize in an aqueous media to form the characteristic iodide ion. Exemplary o! the iodide salts which may be used as indicator' materials are potassium iodide, sodium iodide, and ammonium iodide. in addition to the requirement that the salt be ionizable, it should also be noted that the 3 cationic portion of the molecule must not interfere with the enzymatic catalysis of the glucose oxidation. Of the suitable iodide salt, economic considerations and availability suggest that potassium iodide is the preferable salt of the present invention.
The principles underlying the basic reactions of enzyme tests for glucose are well known. Glucose oxidase catalyzes the aerobic oxidation of gucose to produce gluconic acid and hydrogen peroxide. In this reaction hydrogen removed from the glucose combines with atmospheric oxygen to form the hydrogen peroxide. This reaction may be represented by the following schematic equation:
Glucose O; giuconic acid H1O:
in addition to the use of the enzyme glucose oxidase, the system as noted above must include a material having pcroxidative activity. Among the materials having this activity, a preferable compound is horseradish peroxidase or potato peroxidase. However in addition to these naturally occurring peroxidase materials, other organic materials having similar activity may also be utilized. Exemplary of these other materials are normal whole blood, red blood cells alone, lyophilzcd whole blood, urohemin, metalloporphyrins and similar compounds.
in order to produce a test having the desired stability, reactivity and sensitivity, the aforementioned ingredients when contacted with the fluid being tested should be buffered at a hydrogen ion concentration of about from pll 3.4 to 7.2 with a preferable range of about from PH 5.0 to pH 6.0. Of the numerous buffer: which may be utilized to maintain the pH of the ingredients in the dcsircd range, it has been found that a citric acid-sodium citrate buffer achieves the desired results with a minimum of interferences with the enzymatic reactions involved in the test system. Other means may however be used to maintain an isohydric pH condition such as phosphate, tartrate and glutamate buffer systems.
In addition to the utilization of an iodide salt as a chromogcn in the present test system, it is preferable that a second indicator substance be included in the test composition. in this regard, it has been found that the inclusion of a blue dyestuff in the test formulation results in a gradient response to the presence of various concentrations of glucose which ranges from blue through various shades of green to brown as the concentration of glucose increases. f such blue dyestuffs, it has also been found preferable to utilize a chromogen which goes from blue to colorless when being oxidized by the hydrogen peroxide produced in the test reaction system. in this regard dyestuffs such as indigo-carmlne and brilliant blue FCF are ideally suited as chromogens. Other dyestuff materials which may be utilized in the present invention are aniline blue, cyanol blue, patent blue, xylene blue .V and Comessie brilliant blue.
in addition to the above test composition constituents which actively participate in the test reaction, other adiuvants may be utilized. Such adjuvants include thickening agents which also function as enzyme stabilizers. In this regard it has been found that a preferable test composition includes the utiiiaztion of such materials as polyvinylpyrrolidone, sodium alginate, gelatin, bovine serum a bumin, polyvinyl alcohol and an interpolymer of methyivinylether and maleic anhydride such-as that described in US. Pat. No. 3,453,180 and known commercially as Grantrcz AN. The preparation of a test composition comprising the active ingredients above noted and including Grantrez and PVP had been found to be exceptionally stable. in regard to the use of polyvinylpyrrolidone, it has been found that the use of this material results in the formation of a color complex with the free iodide which results in an improved indicator system. Such use is preferred in the present composition.
As noted hereinabove, when utilizing an iodide salt as an indicator material in an enzymatic glucose test, it has been found necessary to include in such composition a means for retarding or preventing the adherence of excess liquid sample to the test device. In this regard a semipermeable membrane such as ethylcellulose has been found to prevent such a water retention. Other eellulosic compounds and film forming substances which achieve the same effect may also be utilized. Such compounds include the cellulose ethers and esters as well as various other hydrophobic film forming polymeric materials. Ethylceiluiose has been found especially advantageous for use in the present invention.
As far as actual proportions of active ingredients is concerned, it has been found that a reasonably wide range of concentrations may be used. As a general guide, the following ranges of concentrations may be employed. These figures are based on the solution used to incorporate the test system constituents with the carrier member therefor.
Quantity per ml.
mam restaurant-z Glucose oxidase units 16,000-33,000 Peroxidative active substance mg.. 40-60 Iodide salt g.. l-2 Second chromogen (blue dyestuff) mg l-20 Film forming polymer g 3 0.5-1
1 Based on an assay of 8000 Worthington Units (WU)/mcg. Dissolved in an organic colvent such as benzlne.
As noted at the beginning of this disclosure, it is preferable in the present invention to incorporate the test com position on or with a carrier member and to utilize this combination as a dip and read test device. This may be achieved by various methods, which include, impregnating a bibulous material with a solution of the test composition and thereafter drying the impregnated test device, adhesively fixing to the surface of the carrier, a finely divided, dry, intimate mixture of the ingredients, and the like. The preferable mode of preparation is the impregnation of a bibulous carrier with a. solution or solutions of the test composition, followed by drying. When a bibulous carrier is employed, the carrier material may be any of the variety of substances. For example, filter paper, wood strips, synthetic plastic fiberous materials, nonwoven orwoven fabrics and so on may be utilized in this embodiment. The preferable bibulous material is filter paper having a thickness of about 0.01 inch to about 0.02 inch. Once the carrier member has been impregnated with the basic test composition and dried, and semi-permeable membrane may be then applied by utilizing same in an organic solvent and effecting a second dip of the test device in the polymeric film former followed by a second drying. Another mode of preparation of the present test device simply comprises mixing the test composition with a film .forming polymeric substance and attaching such mixture to a carrier or handle means therefor.
The mode of use of the test device of the present invention will now be described. In conducting the test for glucose, thedevice is immersed into the fluid being tested which usually is a urine sample and immediately withdrawn. This is done since the pH of the moistened device must usually be dominated by the buffer in the test composition. If the test device were allowed to remain in the fluid for any length of time, there would be a danger that the test composition ingredients would be leached from the carrier into the fluid. However such leaching effect is substantially retarded by the utilization of the semi-permeable membrane described hereinabove. The color developed due to the presence of gulcose in the test liquid is then read by visual comparison with a previously prepared color chart. Various instrumental metrods may also be employed to determine the quality of the color developed,
thus increasing the accuracy of the test by removin the subjective determination of color by the human eye. However as also noted hereinabove, the excellent gradient color response due to the novel inclusion of two chromogcnic substances into the present test composition substantially alleviates such subjective human error.
The actual compounding of the test composition of the present invention will be illustrated by the following example which is included for illustrative purposes only and is not to be construed as placing any limitation upon the inventive concept as disclosed herein.
EXAMPLE The following components were mixed, stepwise for the preparation of 100 ml. of mix.
Component: Quantity (1) Potassium iodide g 1.0 (2) Brilliant blue FCF (FD and C blue No.
l) mg 10.4 (3) Distilled water ml 53 (4) Citric acid, anhydrous g 0.595 (5) Sodium eitrate-2H,O g 5.23 (6) Gantrez. AN 139 (l0% aqueous solution) ml. (7) Polyvinylpyrrolidone (l0% aqueous solution) ml- 5 (8) Peroxidase mg 1 50 (9) Glucose oxidase ml-- 3 33 ZtOOO Worthington untta/ntcg.
' i000 units/ml.
Whatman 3 MM paper was impregnated with the above solution, allowed to drain and dried in a tunnel dryer set at 85 C. for 7 minutes. After removal from the drying tunnel, the impregnated paper was dipped into a solution of 0.85 grams of ethyl cellulose in 100 ml. of benzene. After removal from this second impregnating solultOl'i the paper was again dried, cut into small squares a proximately 5 mm. by 5 mm. and attached to and end of a strip of fluid impervious plastic film 5 mm. wide and approximately 6 cm. long.
The above prepared test devices were contacted with various urines containing increments of glucose of from O to 2% by weight. The results were as follows:
Glucose concentration Color developed As can be noted from the above results, excellent glucose quantitation was achieved employing a formulation prepared according to the teachings of the present invention. A commercial product utilizing ortho-tolidine as an indicator material rather than an iodide salt, was somewhat capable of quantitating the above noted glucose concentration up to but not more than 0.50 gram percent glucose.
what is claimed is:
i. in a test device for the semi-quantitative determination of glucose in urine comprising a bibulous, fibrous carrier member incorporating, in combination, glucose oxidase, a substance having peroxidative activity, and a water soluble iodide salt, the improvement which comprises a hydrophobic coating encompassing the fibers of the bibulous carrier member, said hydrophobic coating being the dry residue deposited through the saturation of the bibulous carrier member with an organic solvent \(iittliOfl of from 0.5 to L0 grams per I00 ml. of a lilm forming material selected from the group con- 6 sisting of hydrophobic cellulose ethers and esters.
2. A test device as in claim 1 wherein the test device additionally includes the presence of a blue dyestufi.
3. A test device as in claim 2 wherein the said dyestufi is selected from the group consisting of brilliant blue FCF, indigo carmine, aniline blue, patent blue, xylene blue V and Comassie blue.
4. A test device as in claim 1 wherein the test device further includes a buffer for maintaining the system in a pH range of from about pH 3.4 to pH 7.2.
5. A test device as in claim 1 wherein the film forming material is ethyl cellulose.
6. A test device as in claim 1 where the water soluble iodide salt is selected from the group consisting of potassium iodide, sodium iodide and ammonium iodide.
7. A test device as in claim 6 wherein the iodide salt is potassium iodide.
8. A test device as in claim 1 wherein the material having peroxidative activity is peroxidase.
9. A test device for the semi-quantitative detection of glucose in urine comprising a bibulous, fibrous paper carrier impregnated with the dry residue of an aqueous solution having the following proportions of ingredients per ml. of solution:
Glucose oxidase units 16000-33000 Peroxidative active substance mg 40-60 Water soluble iodide salt g l-Z and thereafter coated with the dry residue of a saturating solution of about from 0.5 to 1.0 grams of ethyl cellulose per 100 ml. of benzene.
10. A test device as in claim 9 wherein the solution additionally contains 1 to 20 mg. of a blue dycstufi.
11. A test device as in claim 10 wherein the blue dyestuff is brilliant blue FCF.
12. A test device as in claim 1 wherein the carrier member is bibulous paper.
13. A process for the semi-quantitative determination of glucose in urine comprising contacting the urine with a test device consisting essentially of a bibulous, fibrous carrier member incorporating the dry residue of a solution of glucose oxidase, a substance having peroxidative activity, and a water soluble iodide salt, the fibers of said carrier member being encompassed by a hydrophobic coating, said hydrophobic coating being the dry residue deposited through the saturation of the bibulous carrier with an organic solvent solution of from 0.5 to l.() grams per I00 ml. of a film forming material selected from the group consisting of hydrophobic cellulose ethers and esters. immediately removing the test device from contact with said urine and within about one minute comparing the color developed hereon with a previously prepared standard color fit e 14. A process as in claim 13 wherein the residue additionally contains a blue dyestulf.
15. A process as in claim 13 wherein the water soluble iodide salt is selected from the group consisting of potassium iodide, sodium iodide and ammonium iodide.
10. In a process for the preparation of a test device for the semi-quantitative determination of glucose in urine comprising the preparation of a solution of glucose oxidane, a substance having peroxidative activity, and a water soluble iodide salt, incorporating said solution with a bibulous, fibrous carrier member therefor, drying said solution and carrier member, the improvement which comprises thereafter saturating said carrier member with an' 'o'rgaiiie solvenisolu'fion of from 0.5 (5 T0 grams per l00 ml. of a film-forming material selected from the group consisting of hydro phobic cellulose ethers and esters resulting in the deposition of a dry. hydrophobic residue coating {11C carrier memb r.
References Cited UNITED STATES PATENTS Adams et a1. 195-103.!) C X Fonner 195103.5 C Scott l95l03.5 C Kcston 23-253 T? Rey cl a1 195-1035 C Harvill ct al. 195-1035 R 8 OTHER REFERENCES Wilson et 111., "Comprehensive Anal. Chem.," Vol. 1c (1962), p. 362.
Welcher, "Organic Analytical Reagents," Vol. IV a (1948),p.505.
U.S. C1. X.R. 195-99; 23-253 T1
Priority Applications (14)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US00866730A US3814668A (en) | 1969-10-15 | 1969-10-15 | Method and device for the semi-quantitative determination of glucose in aqueous fluids |
| CA094236A CA926282A (en) | 1969-10-15 | 1970-09-28 | Method and device for the semi-quantitative determination of glucose in aqueous fluids |
| ZA706650*A ZA706650B (en) | 1969-10-15 | 1970-09-29 | Method and device for the semi-quantitative determination of glucose in aqeous fluids |
| CH1494370A CH558530A (en) | 1969-10-15 | 1970-10-08 | TEST PRODUCTS FOR THE HALF-QUANTITATIVE DETERMINATION OF GLUCOSE IN Aqueous LIQUIDS, METHOD FOR MANUFACTURING THE TEST PRODUCT AND THEIR USE. |
| ES384417A ES384417A1 (en) | 1969-10-15 | 1970-10-10 | A TEST DEVICE AND A PROCEDURE FOR THE SEMIQUANTITATIVE DETERMINATION OF GLUCOSE IN AQUEOUS FLUIDS. |
| GB4866970A GB1320957A (en) | 1969-10-15 | 1970-10-13 | Test device for the determination of glucose in aqueous fluids |
| NL7014994A NL7014994A (en) | 1969-10-15 | 1970-10-13 | |
| DE19702050481 DE2050481C3 (en) | 1969-10-15 | 1970-10-14 | Diagnostic agent for the semi-quantitative determination of glucose in urine |
| DK521970AA DK139795B (en) | 1969-10-15 | 1970-10-14 | Sample preparation for semi-quantitative determination of glucose in urine. |
| SE13894/70A SE360178B (en) | 1969-10-15 | 1970-10-14 | |
| BE70@@@@@@@@A BE757507A (en) | 1969-10-15 | 1970-10-14 | PERFECTED METHOD AND ELEMENT FOR SEMI-QUANTITATIVE ASSESSMENT OF GLUCOSE IN AQUEOUS LIQUIDS |
| FR7037103A FR2065939A5 (en) | 1969-10-15 | 1970-10-14 | |
| NO703869A NO130520C (en) | 1969-10-15 | 1970-10-14 | |
| JP45089744A JPS5039558B1 (en) | 1969-10-15 | 1970-10-14 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US00866730A US3814668A (en) | 1969-10-15 | 1969-10-15 | Method and device for the semi-quantitative determination of glucose in aqueous fluids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3814668A true US3814668A (en) | 1974-06-04 |
Family
ID=25348274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US00866730A Expired - Lifetime US3814668A (en) | 1969-10-15 | 1969-10-15 | Method and device for the semi-quantitative determination of glucose in aqueous fluids |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3814668A (en) |
| JP (1) | JPS5039558B1 (en) |
| BE (1) | BE757507A (en) |
| CA (1) | CA926282A (en) |
| CH (1) | CH558530A (en) |
| DK (1) | DK139795B (en) |
| ES (1) | ES384417A1 (en) |
| FR (1) | FR2065939A5 (en) |
| GB (1) | GB1320957A (en) |
| NL (1) | NL7014994A (en) |
| NO (1) | NO130520C (en) |
| SE (1) | SE360178B (en) |
| ZA (1) | ZA706650B (en) |
Cited By (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE28575E (en) * | 1971-03-01 | 1975-10-21 | Indicator for detecting hydrogen peroxide and peroxidative compounds containing alpha naphthoflavone | |
| US3920580A (en) * | 1973-07-12 | 1975-11-18 | Miles Lab | Liquid control solution |
| US3964871A (en) * | 1974-12-18 | 1976-06-22 | Becton, Dickinson And Company | Method and device for detecting glucose |
| US3971702A (en) * | 1974-01-09 | 1976-07-27 | Shionogi & Co., Ltd. | Diagnostic composition for saccharide determination |
| US4042329A (en) * | 1974-12-18 | 1977-08-16 | Becton, Dickinson And Company | Method and device for detecting cholesterol |
| US4059407A (en) * | 1976-04-14 | 1977-11-22 | Becton, Dickinson And Company | Disposable chemical indicators |
| US4066408A (en) * | 1974-10-16 | 1978-01-03 | Ab Kabi | Chromogen-reactive-indicator preparations containing a 3,3'-di(carbonyloxy- or sulfonyloxy-group-containing) benzidine derivative chromogen |
| US4160008A (en) * | 1978-01-26 | 1979-07-03 | Miles Laboratories, Inc. | Multilayered test device for determining the presence of a liquid sample component, and method of use |
| EP0036543A1 (en) * | 1980-03-20 | 1981-09-30 | Miles Laboratories, Inc. | Improved method and device for the semiquantitative determination of glucose in aqueous fluids and method of preparing the device |
| US4340669A (en) * | 1981-02-12 | 1982-07-20 | Miles Laboratories, Inc. | System for the determination of glucose in fluids |
| US4391906A (en) * | 1981-02-12 | 1983-07-05 | Miles Laboratories, Inc. | System for the determination of glucose in fluids |
| US4391905A (en) * | 1981-02-12 | 1983-07-05 | Miles Laboratories, Inc. | System for the determination of glucose in fluids |
| WO1985001747A1 (en) * | 1983-10-17 | 1985-04-25 | Inomedix, Incorporated | Device for rapid quantitative analysis of a fluid |
| US4621049A (en) * | 1984-11-19 | 1986-11-04 | Miles Laboratories, Inc. | Enzymatic high range glucose test |
| US4690815A (en) * | 1985-08-15 | 1987-09-01 | Charles Of The Ritz Group Ltd. | Method for testing skin for presence of moisturizer |
| US4956300A (en) * | 1982-01-05 | 1990-09-11 | Helena Laboratories Corporation | Aid for determining the presence of occult blood, method of making the aid, and method of using the aid |
| US4981805A (en) * | 1980-01-18 | 1991-01-01 | Fuji Photo Film Co., Ltd. | Method of using chemical analysis slide |
| US5081040A (en) * | 1987-06-29 | 1992-01-14 | Helena Laboratories Corporation | Composition and kit for testing for occult blood in human and animal excretions, fluids, or tissue matrixes |
| WO1992022806A1 (en) * | 1991-06-17 | 1992-12-23 | Serim Research Corporation | Test for per acids |
| US5192693A (en) * | 1980-01-18 | 1993-03-09 | Fuji Photo Film Co., Ltd. | Method of using chemical analysis slide |
| US5196167A (en) * | 1989-04-04 | 1993-03-23 | Helena Laboratories Corporation | Fecal occult blood test product with positive and negative controls |
| US5217874A (en) * | 1989-04-04 | 1993-06-08 | Helena Laboratories Corporation | Fecal occult blood test product with positive and negative controls |
| US5273888A (en) * | 1984-01-16 | 1993-12-28 | Helena Laboratories Corporation | Chemical test kit and method for determining the presence of blood in a specimen and for verifying the effectiveness of the chemicals |
| US5434057A (en) * | 1994-02-02 | 1995-07-18 | Quidel Corporation | Sperm motility assay and devices |
| US5702913A (en) * | 1983-12-21 | 1997-12-30 | Helena Laboratories Corporation | Chromgen-reagent test system |
| US5906916A (en) * | 1997-11-12 | 1999-05-25 | Integrated Biomedical Technology Inc. | Peroxide test strip |
| US6087089A (en) * | 1997-11-12 | 2000-07-11 | Integrated Biomedical Technology, Inc. | Peroxide and chlorine test strip |
| US6444169B1 (en) | 2001-06-18 | 2002-09-03 | Ralston Purina Company | Test-device for threshold glucose detection in urine |
| US20030068666A1 (en) * | 2001-10-05 | 2003-04-10 | Zweig Stephen Eliot | Dual glucose-hydroxybutyrate analytical sensors |
| US20060051738A1 (en) * | 2001-10-05 | 2006-03-09 | Zweig Stephen E | Dual glucose-turbidimetric analytical sensors |
| US20090035865A1 (en) * | 2007-08-01 | 2009-02-05 | Demoor Colette Pamela | Moisture sensor |
| US20090047176A1 (en) * | 2007-08-16 | 2009-02-19 | Cregger Tricia A | Indicator for monitoring a sterilization process |
| US20100255592A1 (en) * | 2007-05-02 | 2010-10-07 | Siemens Healthcare Diagnostics Inc. | Piezo dispensing of a diagnostic liquid onto a reagent surface |
| WO2014126995A1 (en) | 2013-02-14 | 2014-08-21 | Siemens Healthcare Diagnostics Inc. | Reduction of false positive on reagent test devices |
| US9572922B2 (en) | 2012-12-21 | 2017-02-21 | Larry Leonard | Inventive diabetic systems, tools, kits, and supplies for better diabetic living and mobility |
| US9606103B2 (en) | 2011-12-16 | 2017-03-28 | Siemens Healthcare Diagnostics Inc. | Waste ramp for reagent cards |
| EP3301433A1 (en) | 2012-03-09 | 2018-04-04 | Siemens Healthcare Diagnostics Inc. | Calibration method for reagent card analyzers |
| CN108120713A (en) * | 2017-12-20 | 2018-06-05 | 青岛汉唐生物科技有限公司 | A kind of Tes-Tape and preparation method thereof |
| WO2022226504A1 (en) | 2021-04-23 | 2022-10-27 | Siemens Healthcare Diagnostics Inc. | Analyzer having automatic test type sensing |
| EP4164754A1 (en) | 2020-06-11 | 2023-04-19 | Siemens Healthcare Diagnostics, Inc. | Reagent strip counterfeit protection |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT347600B (en) | 1974-11-11 | 1979-01-10 | Wellcome Found | TEST EQUIPMENT |
| US4717658A (en) * | 1985-12-03 | 1988-01-05 | Miles Inc. | Gram negative bacteria screening method with horseshoe crab amebocyte lysate (LAL) |
| CN106323723B (en) * | 2016-11-30 | 2019-01-22 | 宁夏大学 | double blue staining |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3183173A (en) * | 1963-06-10 | 1965-05-11 | Miles Lab | Test composition for detecting hydrogen peroxide |
| US3438737A (en) * | 1965-10-01 | 1969-04-15 | Miles Lab | Protein test composition,device and method |
-
1969
- 1969-10-15 US US00866730A patent/US3814668A/en not_active Expired - Lifetime
-
1970
- 1970-09-28 CA CA094236A patent/CA926282A/en not_active Expired
- 1970-09-29 ZA ZA706650*A patent/ZA706650B/en unknown
- 1970-10-08 CH CH1494370A patent/CH558530A/en not_active IP Right Cessation
- 1970-10-10 ES ES384417A patent/ES384417A1/en not_active Expired
- 1970-10-13 NL NL7014994A patent/NL7014994A/xx unknown
- 1970-10-13 GB GB4866970A patent/GB1320957A/en not_active Expired
- 1970-10-14 BE BE70@@@@@@@@A patent/BE757507A/en unknown
- 1970-10-14 FR FR7037103A patent/FR2065939A5/fr not_active Expired
- 1970-10-14 JP JP45089744A patent/JPS5039558B1/ja active Pending
- 1970-10-14 SE SE13894/70A patent/SE360178B/xx unknown
- 1970-10-14 DK DK521970AA patent/DK139795B/en not_active IP Right Cessation
- 1970-10-14 NO NO703869A patent/NO130520C/no unknown
Cited By (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE28575E (en) * | 1971-03-01 | 1975-10-21 | Indicator for detecting hydrogen peroxide and peroxidative compounds containing alpha naphthoflavone | |
| US3920580A (en) * | 1973-07-12 | 1975-11-18 | Miles Lab | Liquid control solution |
| US3971702A (en) * | 1974-01-09 | 1976-07-27 | Shionogi & Co., Ltd. | Diagnostic composition for saccharide determination |
| US4066408A (en) * | 1974-10-16 | 1978-01-03 | Ab Kabi | Chromogen-reactive-indicator preparations containing a 3,3'-di(carbonyloxy- or sulfonyloxy-group-containing) benzidine derivative chromogen |
| US3964871A (en) * | 1974-12-18 | 1976-06-22 | Becton, Dickinson And Company | Method and device for detecting glucose |
| US4042329A (en) * | 1974-12-18 | 1977-08-16 | Becton, Dickinson And Company | Method and device for detecting cholesterol |
| US4059407A (en) * | 1976-04-14 | 1977-11-22 | Becton, Dickinson And Company | Disposable chemical indicators |
| US4160008A (en) * | 1978-01-26 | 1979-07-03 | Miles Laboratories, Inc. | Multilayered test device for determining the presence of a liquid sample component, and method of use |
| US4981805A (en) * | 1980-01-18 | 1991-01-01 | Fuji Photo Film Co., Ltd. | Method of using chemical analysis slide |
| US5192693A (en) * | 1980-01-18 | 1993-03-09 | Fuji Photo Film Co., Ltd. | Method of using chemical analysis slide |
| EP0036543A1 (en) * | 1980-03-20 | 1981-09-30 | Miles Laboratories, Inc. | Improved method and device for the semiquantitative determination of glucose in aqueous fluids and method of preparing the device |
| US4303753A (en) * | 1980-03-20 | 1981-12-01 | Miles Laboratories, Inc. | Method and device for the semiquantitative determination of glucose in aqueous fluids |
| US4340669A (en) * | 1981-02-12 | 1982-07-20 | Miles Laboratories, Inc. | System for the determination of glucose in fluids |
| US4391906A (en) * | 1981-02-12 | 1983-07-05 | Miles Laboratories, Inc. | System for the determination of glucose in fluids |
| US4391905A (en) * | 1981-02-12 | 1983-07-05 | Miles Laboratories, Inc. | System for the determination of glucose in fluids |
| US4956300A (en) * | 1982-01-05 | 1990-09-11 | Helena Laboratories Corporation | Aid for determining the presence of occult blood, method of making the aid, and method of using the aid |
| WO1985001747A1 (en) * | 1983-10-17 | 1985-04-25 | Inomedix, Incorporated | Device for rapid quantitative analysis of a fluid |
| US5702913A (en) * | 1983-12-21 | 1997-12-30 | Helena Laboratories Corporation | Chromgen-reagent test system |
| US5273888A (en) * | 1984-01-16 | 1993-12-28 | Helena Laboratories Corporation | Chemical test kit and method for determining the presence of blood in a specimen and for verifying the effectiveness of the chemicals |
| US4621049A (en) * | 1984-11-19 | 1986-11-04 | Miles Laboratories, Inc. | Enzymatic high range glucose test |
| US4690815A (en) * | 1985-08-15 | 1987-09-01 | Charles Of The Ritz Group Ltd. | Method for testing skin for presence of moisturizer |
| US5081040A (en) * | 1987-06-29 | 1992-01-14 | Helena Laboratories Corporation | Composition and kit for testing for occult blood in human and animal excretions, fluids, or tissue matrixes |
| US5196167A (en) * | 1989-04-04 | 1993-03-23 | Helena Laboratories Corporation | Fecal occult blood test product with positive and negative controls |
| US5217874A (en) * | 1989-04-04 | 1993-06-08 | Helena Laboratories Corporation | Fecal occult blood test product with positive and negative controls |
| WO1992022806A1 (en) * | 1991-06-17 | 1992-12-23 | Serim Research Corporation | Test for per acids |
| US5434057A (en) * | 1994-02-02 | 1995-07-18 | Quidel Corporation | Sperm motility assay and devices |
| US5906916A (en) * | 1997-11-12 | 1999-05-25 | Integrated Biomedical Technology Inc. | Peroxide test strip |
| US6087089A (en) * | 1997-11-12 | 2000-07-11 | Integrated Biomedical Technology, Inc. | Peroxide and chlorine test strip |
| US6444169B1 (en) | 2001-06-18 | 2002-09-03 | Ralston Purina Company | Test-device for threshold glucose detection in urine |
| US6599474B2 (en) | 2001-06-18 | 2003-07-29 | Nestec, Ltd. | Threshold glucose detection in urine |
| US6682937B2 (en) | 2001-06-18 | 2004-01-27 | Hach Company | Threshold glucose detection in urine |
| US20030068666A1 (en) * | 2001-10-05 | 2003-04-10 | Zweig Stephen Eliot | Dual glucose-hydroxybutyrate analytical sensors |
| US6984307B2 (en) | 2001-10-05 | 2006-01-10 | Stephen Eliot Zweig | Dual glucose-hydroxybutyrate analytical sensors |
| US20060051738A1 (en) * | 2001-10-05 | 2006-03-09 | Zweig Stephen E | Dual glucose-turbidimetric analytical sensors |
| US7758744B2 (en) | 2001-10-05 | 2010-07-20 | Stephen Eliot Zweig | Dual glucose-turbidimetric analytical sensors |
| US8304254B2 (en) | 2007-05-02 | 2012-11-06 | Siemens Healthcare Diagnostics Inc. | Piezo dispensing of a diagnostic liquid onto a reagent surface |
| US20100255592A1 (en) * | 2007-05-02 | 2010-10-07 | Siemens Healthcare Diagnostics Inc. | Piezo dispensing of a diagnostic liquid onto a reagent surface |
| US20090035865A1 (en) * | 2007-08-01 | 2009-02-05 | Demoor Colette Pamela | Moisture sensor |
| US8512633B2 (en) | 2007-08-16 | 2013-08-20 | American Sterilizer Company | Indicator for monitoring a sterilization process |
| US20090047176A1 (en) * | 2007-08-16 | 2009-02-19 | Cregger Tricia A | Indicator for monitoring a sterilization process |
| US11187694B2 (en) | 2011-12-16 | 2021-11-30 | Siemens Healthcare Diagnostics Inc. | Method for assembling an automated analyzer, waste ramp, and waste receptacle for reagent cards |
| US9606103B2 (en) | 2011-12-16 | 2017-03-28 | Siemens Healthcare Diagnostics Inc. | Waste ramp for reagent cards |
| US10444221B2 (en) | 2011-12-16 | 2019-10-15 | Siemens Healthcare Diagnostics Inc. | Method of transferring a reagent card from a card travel surface of an automated analyzer to a waste receptacle |
| EP3301433A1 (en) | 2012-03-09 | 2018-04-04 | Siemens Healthcare Diagnostics Inc. | Calibration method for reagent card analyzers |
| US11035799B2 (en) | 2012-03-09 | 2021-06-15 | Siemens Healthcare Diagnostics Inc. | Calibration method for reagent card analyzers |
| US12146835B2 (en) | 2012-03-09 | 2024-11-19 | Siemens Healthcare Diagnostics Inc. | Calibration method for reagent card analyzers |
| US9572922B2 (en) | 2012-12-21 | 2017-02-21 | Larry Leonard | Inventive diabetic systems, tools, kits, and supplies for better diabetic living and mobility |
| US9612249B2 (en) | 2013-02-14 | 2017-04-04 | Siemens Healthcare Diagnostics Inc. | Reduction of false positive on reagent test devices |
| WO2014126995A1 (en) | 2013-02-14 | 2014-08-21 | Siemens Healthcare Diagnostics Inc. | Reduction of false positive on reagent test devices |
| CN108120713A (en) * | 2017-12-20 | 2018-06-05 | 青岛汉唐生物科技有限公司 | A kind of Tes-Tape and preparation method thereof |
| EP4164754A1 (en) | 2020-06-11 | 2023-04-19 | Siemens Healthcare Diagnostics, Inc. | Reagent strip counterfeit protection |
| WO2022226504A1 (en) | 2021-04-23 | 2022-10-27 | Siemens Healthcare Diagnostics Inc. | Analyzer having automatic test type sensing |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2065939A5 (en) | 1971-08-06 |
| ES384417A1 (en) | 1973-09-16 |
| DE2050481A1 (en) | 1971-04-29 |
| SE360178B (en) | 1973-09-17 |
| BE757507A (en) | 1971-03-16 |
| DK139795B (en) | 1979-04-17 |
| DK139795C (en) | 1979-10-15 |
| JPS5039558B1 (en) | 1975-12-17 |
| GB1320957A (en) | 1973-06-20 |
| NO130520C (en) | 1974-12-27 |
| CA926282A (en) | 1973-05-15 |
| CH558530A (en) | 1975-01-31 |
| DE2050481B2 (en) | 1976-12-23 |
| ZA706650B (en) | 1971-05-27 |
| NO130520B (en) | 1974-09-16 |
| NL7014994A (en) | 1971-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3814668A (en) | Method and device for the semi-quantitative determination of glucose in aqueous fluids | |
| US3092465A (en) | Diagnostic test device for blood sugar | |
| US3298789A (en) | Test article for the detection of glucose | |
| US3411887A (en) | Diagnostic composition | |
| US4973549A (en) | Quantitative diagnostic assay employing signal producing agent bound to support and measuring migration distance of detectable signal | |
| EP0071934B1 (en) | Method for preparing a color stable chromogenic analytical element | |
| US3145086A (en) | Diagnostic composition | |
| US3598704A (en) | Diagnostic device for various sugars | |
| US4211845A (en) | Glucose indicator and method | |
| US3453180A (en) | Test article | |
| US4673654A (en) | Composition for determining peroxidase-like activity of hemoglobin | |
| US3654180A (en) | Indicator for detecting hydrogen peroxide and peroxidative compounds containing alpha naphthoflavone | |
| US3123443A (en) | Composition for diagnosing glucose | |
| JPS596900A (en) | Analytical element and method of measuring high glucose and method and system for measuring sugar content of whole blood using same | |
| US4273868A (en) | Color stable glucose test | |
| US5204267A (en) | Method of glucose stabilization and analysis in dried blood spot samples | |
| JPH04237500A (en) | Composition and method for assay of ketone body | |
| JPH0578317B2 (en) | ||
| CS207346B2 (en) | Chemical indication papers | |
| US3016292A (en) | Diagnostic composition | |
| US4476222A (en) | Test piece for quantitative analysis of substances in body fluids | |
| US3266868A (en) | Diagnostic composition and test indicator | |
| US4132527A (en) | Diagnostic compositions, diagnosing instruments, and methods of manufacturing same | |
| US4803158A (en) | Composition used for the determination of beta-hydroxybutyric acid and a method for preparing the said composition | |
| US3042496A (en) | Diagnostic composition |